The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancer.
Autorzy:
HelfandBT; NorthShore University HealthSystem, Evanston, Illinois, United States of America. Paterakos M; NorthShore University HealthSystem, Evanston, Illinois, United States of America. Wang CH; NorthShore University HealthSystem, Evanston, Illinois, United States of America. Talaty P; NorthShore University HealthSystem, Evanston, Illinois, United States of America. Abran J; Exact Sciences Corporation, Madison, Wisconsin, United States of America. Bennett J; Exact Sciences Corporation, Madison, Wisconsin, United States of America. Hall DW; Exact Sciences Corporation, Madison, Wisconsin, United States of America. Lehman A; Exact Sciences Corporation, Madison, Wisconsin, United States of America. Aboushwareb T; Exact Sciences Corporation, Madison, Wisconsin, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Sep 01; Vol. 17 (9), pp. e0273782. Date of Electronic Publication: 2022 Sep 01 (Print Publication: 2022).
Subtyping of common complex diseases and disorders by integrating heterogeneous data. Identifying clusters among women with lower urinary tract symptoms in the LURN study.
Autorzy:
Andreev VP; Arbor Research Collaborative for Health, Ann Arbor, Michigan, United States of America. Helmuth ME; Arbor Research Collaborative for Health, Ann Arbor, Michigan, United States of America. Liu G; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, United States of America. Smith AR; Arbor Research Collaborative for Health, Ann Arbor, Michigan, United States of America. Merion RM; Arbor Research Collaborative for Health, Ann Arbor, Michigan, United States of America. Yang CC; Department of Urology, University of Washington, Seattle, Washington, United States of America. Cameron AP; Department of Urology, University of Michigan, Ann Arbor, Michigan, United States of America. Jelovsek JE; Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina, United States of America. Amundsen CL; Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina, United States of America. HelfandBT; Department of Urology, NorthShore University HealthSystem, Evanston, Illinois, United States of America. Bradley CS; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, Iowa, United States of America. DeLancey JOL; Departments of Obstetrics and Gynecology and Urology, University of Michigan, Ann Arbor, Michigan, United States of America. Griffith JW; Department of Medical Social Sciences, Northwestern University, Chicago, Illinois, United States of America. Glaser AP; Department of Urology, NorthShore University HealthSystem, Evanston, Illinois, United States of America. Gillespie BW; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, United States of America. Clemens JQ; Department of Urology, University of Michigan, Ann Arbor, Michigan, United States of America. Lai HH; Department of Surgery, Washington University, St Louis, Missouri, United States of America.
Assessing the clinical utility of genetic risk scores for targeted cancer screening.
Autorzy:
Conran CA; University of Illinois College of Medicine, Chicago, IL, USA. . Shi Z; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. Resurreccion WK; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. Na R; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. HelfandBT; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. Genova E; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. Zheng SL; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. Brendler CB; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. Xu J; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
The association between guideline-based exercise thresholds and low testosterone among men in the United States.
Autorzy:
Fantus RJ; Section of Urology, Department of Surgery, University of Chicago Medicine, Chicago, IL, USA.; Division of Urology, Department of Surgery, NorthShore University Health System, Evanston, IL, USA. Chang C; Division of Urology, Department of Surgery, NorthShore University Health System, Evanston, IL, USA. Hehemann MC; Division of Urology, Department of Surgery, NorthShore University Health System, Evanston, IL, USA. Bennett NE; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Brannigan RE; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. HelfandBT; Division of Urology, Department of Surgery, NorthShore University Health System, Evanston, IL, USA. Halpern JA; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Pokaż więcej
Źródło:
Andrology [Andrology] 2020 Nov; Vol. 8 (6), pp. 1712-1719. Date of Electronic Publication: 2020 Jul 12.
Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts.
Autorzy:
Shi Z; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois.; State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, China. Yu H; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois. Wu Y; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. Lin X; State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, China.; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. Bao Q; State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, China. Jia H; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. Perschon C; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois. Duggan D; Translational Genomics Research Institute, Phoenix, Arizona. HelfandBT; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois. Zheng SL; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois. Xu J; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois.; State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, China.; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2019 Jun; Vol. 8 (6), pp. 3196-3205. Date of Electronic Publication: 2019 Apr 09.
Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations.
Autorzy:
Bancroft EK; Oncogenetics Team, Royal Marsden NHS Foundation Trust, London, UK.; Oncogenetics Team, Institute of Cancer Research, London, UK. Saya S; Oncogenetics Team, Royal Marsden NHS Foundation Trust, London, UK.; Oncogenetics Team, Institute of Cancer Research, London, UK. Page EC; Oncogenetics Team, Royal Marsden NHS Foundation Trust, London, UK.; Oncogenetics Team, Institute of Cancer Research, London, UK. Myhill K; Oncogenetics Team, Royal Marsden NHS Foundation Trust, London, UK.; Oncogenetics Team, Institute of Cancer Research, London, UK. Thomas S; Oncogenetics Team, Royal Marsden NHS Foundation Trust, London, UK.; Oncogenetics Team, Institute of Cancer Research, London, UK. Pope J; Oncogenetics Team, Royal Marsden NHS Foundation Trust, London, UK.; Oncogenetics Team, Institute of Cancer Research, London, UK. Chamberlain A; Oncogenetics Team, Royal Marsden NHS Foundation Trust, London, UK.; Oncogenetics Team, Institute of Cancer Research, London, UK. Hart R; Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham, UK. Glover W; Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham, UK. Cook J; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK. Rosario DJ; Department of Urology, Royal Hallamshire Hospital, Sheffield, UK. HelfandBT; John and Carol Walter Center for Urological Health, NorthShore University HealthSystem, Evanston, IL, USA. Hutten Selkirk C; John and Carol Walter Center for Urological Health, NorthShore University HealthSystem, Evanston, IL, USA. Davidson R; Clinical Genetics Department, Queen Elizabeth University Hospital, Glasgow, UK. Longmuir M; Clinical Genetics Department, Queen Elizabeth University Hospital, Glasgow, UK. Eccles DM; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.; Faculty of Medicine, University of Southampton, University Hospital Southampton NHS Foundation Trust, Southampton, UK. Gadea N; High Risk and Cancer Prevention Clinic, Vall d'Hebron University Hospital, Barcelona, Spain. Brewer C; Clinical Genetics Department, Royal Devon and Exeter Hospital, Exeter, UK. Barwell J; Department of Genetics, University of Leicester, Leicester, UK.; Clinical Genetics, University Hospitals Leicester, Leicester, UK. Salinas M; Hereditary Cancer Programme, Catalan Institute of Oncology (ICO-IDIBELL, CIBERONC), L'Hospitalet de Llobregat, Barcelona, Spain. Greenhalgh L; Cheshire and Mersey Clinical Genetics Service, Liverpool Women's Hospital, Liverpool, UK. Tischkowitz M; Academic Department of Medical Genetics, University of Cambridge, Cambridge, UK. Henderson A; Northern Genetics Service, Newcastle upon Tyne Hospitals, Newcastle, UK. Evans DG; Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK. Buys SS; Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT, USA. Eeles RA; Oncogenetics Team, Royal Marsden NHS Foundation Trust, London, UK.; Oncogenetics Team, Institute of Cancer Research, London, UK. Aaronson NK; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Germline mutations in DNA repair genes are associated with bladder cancer risk and unfavourable prognosis.
Autorzy:
Na R; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.; Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Wu Y; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. Jiang G; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. Yu H; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. Lin X; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. Wang M; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China. Conran CA; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. Fantus RJ; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.; Division of Urology, Department of Surgery, University of Chicago Medical Center, Chicago, IL, USA. Zhang N; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. Liu S; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. HelfandBT; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. Zheng SL; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA. Isaacs WB; Department of Urology, James Buchanan Brady Urologic Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA. Ding Q; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. Shen Z; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. Xu J; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2018 Nov; Vol. 122 (5), pp. 808-813. Date of Electronic Publication: 2018 Jun 04.
To PSA or not to PSA? Still a question for men with a family history of prostate cancer.
Autorzy:
Selkirk CG; Center for Medical Genetics, Department of Medicine, NorthShore University HealthSystem, Chicago, IL, USA. HelfandBT; John and Carol Walter Center for Urological Health, Department of Surgery, NorthShore University HealthSystem, Chicago, IL, USA.
Temporary erectile dysfunction after prostate biopsy.
Autorzy:
HelfandBT; North Shore University Health System, Division of Urology, John and Carol Walter Center for Urological Health, Evanston, IL, USA.; University of Chicago, Chicago, IL, USA.
Comparison of patients undergoing laser vaporization of the prostate versus TURP using the ACS-NSQIP database.
Autorzy:
Malik RD; University of Chicago Medical Center, Chicago, IL, USA. Wang CE; NorthShore University Health Systems, Evanston, IL, USA. Lapin B; NorthShore University Health Systems, Evanston, IL, USA. Gerber GS; University of Chicago Medical Center, Chicago, IL, USA. HelfandBT; NorthShore University Health Systems, Evanston, IL, USA.
Nanocytological field carcinogenesis detection to mitigate overdiagnosis of prostate cancer: a proof of concept study.
Autorzy:
Roy HK; Department of Medicine, Boston University Medical Center, Boston, Massachusetts, United States of America. Brendler CB; Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois, United States of America. Subramanian H; Biomedical Engineering Department, Northwestern University, Evanston, Illinois, United States of America. Zhang D; Biomedical Engineering Department, Northwestern University, Evanston, Illinois, United States of America. Maneval C; Biomedical Engineering Department, Northwestern University, Evanston, Illinois, United States of America. Chandler J; Biomedical Engineering Department, Northwestern University, Evanston, Illinois, United States of America. Bowen L; Biomedical Engineering Department, Northwestern University, Evanston, Illinois, United States of America. Kaul KL; Department of Pathology, NorthShore University HealthSystem, Evanston, Illinois, United States of America. HelfandBT; Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois, United States of America. Wang CH; Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois, United States of America. Quinn M; Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois, United States of America. Petkewicz J; Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois, United States of America. Paterakos M; Department of Pathology, NorthShore University HealthSystem, Evanston, Illinois, United States of America. Backman V; Biomedical Engineering Department, Northwestern University, Evanston, Illinois, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Feb 23; Vol. 10 (2), pp. e0115999. Date of Electronic Publication: 2015 Feb 23 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Genetically adjusted prostate-specific antigen values may prevent delayed biopsies in African-American men.
Autorzy:
Donin NM; Department of Urology, New York University Langone Medical Center and Manhattan Veterans Affairs Medical Center, New York, NY, USA. Loeb S; Department of Urology, New York University Langone Medical Center and Manhattan Veterans Affairs Medical Center, New York, NY, USA. Cooper PR; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Roehl KA; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Baumann NA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Catalona WJ; Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. HelfandBT; Division of Urology, NorthShore University Healthcare System, Evanston, IL, USA.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2014 Dec; Vol. 114 (6b), pp. E50-E55. Date of Electronic Publication: 2014 Jul 15.
Typ publikacji:
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
